NCT00158262View on ClinicalTrials.gov

Effect of Propranolol on Preventing Posttraumatic Stress Disorder

PHASE4CompletedINTERVENTIONAL
Enrollment

43

Participants

Timeline

Start Date

September 30, 2004

Primary Completion Date

May 31, 2008

Study Completion Date

May 31, 2008

Conditions
Post-Traumatic Stress Disorder
Interventions
DRUG

Propranolol

Propranolol short-acting or long-acting capsule

DRUG

Placebo

Placebo-matching propranolol short-acting or long-acting capsule

Trial Locations (2)

02114

Massachusetts General Hospital, Boston

02115

Brigham and Women's Hospital, Boston

All Listed Sponsors
collaborator

National Institute of Mental Health (NIMH)

NIH

lead

Massachusetts General Hospital

OTHER

NCT00158262 - Effect of Propranolol on Preventing Posttraumatic Stress Disorder | Biotech Hunter | Biotech Hunter